ACAD-8 is an enzyme that is intricately involved in the metabolic pathway responsible for the breakdown of branched-chain amino acids, specifically valine. It is a mitochondrial protein that facilitates the critical step of dehydrogenation in the catabolic sequence. The precise regulation of ACAD-8 expression is vital for maintaining metabolic homeostasis within cells, especially under varying nutritional and energetic demands. Metabolic adaptability hinges on the functionality of enzymes like ACAD-8, as they ensure the proper utilization of amino acids and the maintenance of energy levels. Understanding the regulation of ACAD-8 is significant not only from a metabolic perspective but also for insights into how cells respond to different states of metabolic flux. Research into the modulation of ACAD-8 expression can shed light on the broader regulatory networks at play within mitochondrial function and energy metabolism.
A diverse array of molecules have been identified that could potentially upregulate the expression of ACAD-8, each interacting with distinct metabolic signaling pathways. For instance, compounds such as fibrates, including fenofibrate and bezafibrate, are known for their lipid-modulating effects and may also play a role in inducing the expression of ACAD-8 by acting as agonists for the peroxisome proliferator-activated receptor alpha (PPARα). This receptor, when activated, initiates a cascade that can lead to the enhanced transcription of genes involved in fatty acid metabolism. Similarly, other compounds like metformin and berberine are known to activate adenosine monophosphate-activated protein kinase (AMPK), which serves as an energy sensor in cells. Activation of AMPK may stimulate the expression of ACAD-8, possibly as a part of the cellular response to energy stress, thereby upregulating mitochondrial fatty acid oxidation enzymes. Moreover, naturally occurring polyphenols such as resveratrol and curcumin may stimulate ACAD-8 expression through their interactions with cellular antioxidants and enzymes involved in the stress response, which could lead to an adaptive increase in mitochondrial enzymes to counteract oxidative stress. These compounds are the focus of intense research due to their potential to induce the expression of ACAD-8, which underscores the complex interplay between diet, metabolism, and cellular regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is a PPARα agonist that can upregulate the transcription of genes involved in fatty acid oxidation, potentially leading to a direct upsurge in ACAD-8 expression to enhance mitochondrial fatty acid β-oxidation. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate activates PPARα, which can lead to an upregulation of fatty acid oxidation genes, including ACAD-8, thereby stimulating the breakdown of branched-chain fatty acids in mitochondrial pathways. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Gemfibrozil's role as a PPARα agonist suggests it could upregulate the expression of ACAD-8, which is crucial for the mitochondrial catabolism of certain amino acids and may help in maintaining energy homeostasis. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
WY 14643, by activating PPARα, has the capacity to stimulate the transcriptional activity of genes like ACAD-8, which would enhance the mitochondrial oxidation of fatty acids. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMPK agonist, might stimulate the expression of ACAD-8 by enhancing the cellular energy state, which in turn could upregulate the mitochondrial fatty acid oxidation process. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can upregulate the expression of genes associated with mitochondrial function and energy metabolism through SIRT1 activation, suggesting a possible enhancement in ACAD-8 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can lead to the transcriptional activation of genes involved in mitochondrial metabolism, which may include an increase in ACAD-8 expression to support energy production through fatty acid metabolism. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
α-Lipoic Acid, as an antioxidant, may stimulate ACAD-8 expression by enhancing the antioxidant defense in mitochondria, possibly to maintain efficient energy production during oxidative stress. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine, by stimulating AMPK, may increase the expression of ACAD-8, which could improve the mitochondrial capacity for fatty acid oxidation and support metabolic health. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, as a PPARγ agonist, could stimulate an increase in ACAD-8 expression, thereby promoting mitochondrial fatty acid oxidation and improving metabolic efficiency. | ||||||